Gene · 6311
Papers3,217
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,217
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Determining the Prognostic Value of Spliceosome-Related Genes in Hepatocellular Carcinoma Patients. | Front Mol Biosci | 2022 | 35281269 | PubTator, text mining | PubMed |
| The Role of VCP Mutations in the Spectrum of Amyotrophic Lateral Sclerosis-Frontotemporal Dementia. | Front Neurol | 2022 | 35273561 | PubTator, text mining | PubMed |
| Genetic variants associated mRNA stability in lung. | BMC Genomics | 2022 | 35272635 | PubTator, text mining | PubMed |
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| Biomarkers in Human Peripheral Blood Mononuclear Cells: The State of the Art in Amyotrophic Lateral Sclerosis. | Int J Mol Sci | 2022 | 35269723 | PubTator, text mining | PubMed |
| The Neurotoxicity of Vesicles Secreted by ALS Patient Myotubes Is Specific to Exosome-Like and Not Larger Subtypes. | Cells | 2022 | 35269468 | PubTator, text mining | PubMed |
| DNA methylation age acceleration is associated with age of onset in Chinese spinocerebellar ataxia type 3 patients. | Neurobiol Aging | 2022 | 35247757 | PubTator, text mining | PubMed |
| Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing. | Sci Adv | 2022 | 35245110 | PubTator, text mining | PubMed |
| VNTR (CAG)n polymorphism of the ATXN2 gene and metabolic parameters of cardiovascular risk associated with the degree of obesity in the Amerindian population of Oaxaca. | Endocrinol Diabetes Nutr (Engl Ed) | 2022 | 35232555 | PubTator, text mining | PubMed |
| Partners in crime: Proteins implicated in RNA repeat expansion diseases. | Wiley Interdiscip Rev RNA | 2022 | 35229468 | PubTator, text mining | PubMed |
| Turnover of the mTOR inhibitor, DEPTOR, and downstream AKT phosphorylation in multiple myeloma cells, is dependent on ERK1-mediated phosphorylation. | J Biol Chem | 2022 | 35216969 | PubTator, text mining | PubMed |
| Inhibition of Polyglutamine Misfolding with D-Enantiomeric Peptides Identified by Mirror Image Phage Display Selection. | Biomolecules | 2022 | 35204656 | PubTator, text mining | PubMed |
| Implications of Poly(A) Tail Processing in Repeat Expansion Diseases. | Cells | 2022 | 35203324 | PubTator, text mining | PubMed |
| Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine. | Toxins (Basel) | 2022 | 35202165 | PubTator, text mining | PubMed |
| Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles. | J Cachexia Sarcopenia Muscle | 2022 | 35194965 | PubTator, text mining | PubMed |
| Adult-onset Niemann-Pick disease type C masquerading as spinocerebellar ataxia. | Mol Genet Genomic Med | 2022 | 35192242 | PubTator, text mining | PubMed |
| Evolution of disability in spinocerebellar ataxias type 1, 2, 3, and 6. | Ann Clin Transl Neurol | 2022 | 35188716 | PubTator, text mining | PubMed |
| A Variant in Genes of the NPY System as Modifier Factor of Machado-Joseph Disease in the Chinese Population. | Front Aging Neurosci | 2022 | 35185528 | PubTator, text mining | PubMed |
| Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study. | Lancet Neurol | 2022 | 35182509 | PubTator, text mining | PubMed |
| Contemporary diagnostics for medically relevant fastidious microorganisms belonging to the genera Anaplasma,Bartonella,Coxiella,OrientiaandRickettsia. | FEMS Microbiol Rev | 2022 | 35175353 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6311/papers?page=36